Coty B.
- Country
- The Netherlands
- Department
- Internal medicine
Research Overview
Data & Insights
Has run more than one trial at 2 of 53 partner sites.
Specializations
Hematologic Disorders
The investigator specializes in the treatment of Essential Thrombocythemia (ET), with particular focus on patients who have demonstrated inadequate response to conventional therapies.
- Treatment-resistant thrombocythemia
- Myeloproliferative disorders
- Alternative therapeutic approaches
Areas of interest include managing hydroxyurea-resistant cases and developing therapeutic strategies for difficult-to-treat blood disorders.
Therapeutic Innovation
Research activities center on evaluating novel therapeutic agents, including bomedemstat, for blood disorders that are challenging to treat with standard protocols.
- Advanced treatment modalities
- Therapy optimization
- Drug resistance management
The investigator focuses on comparing emerging treatments with established therapeutic approaches in hematologic conditions.
Clinical Response Assessment
Expertise in evaluating durable clinical hematologic responses in patients with blood disorders, particularly in the context of treatment-resistant conditions.
- Response monitoring
- Treatment effectiveness
- Patient outcomes assessment
Special interest in determining therapeutic efficacy in cases where standard treatments have proven insufficient.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.